Fritextsökning
Innehållstyper
-
Multiplex Immunofluorescence
New protocol for efficient generation of seven-color, whole slide imaging with ZEISS Axioscan.
-
Gene therapies on clinical hold after tumour found in five‑year‑old
The development of a brain tumour in a study participant has led the FDA to temporarily halt two ongoing gene therapy programs. The affected company, Regenxbio,...
-
How Microscopy Can Help Families Grow
Advanced microscopy solutions can help bypass challenges and natural barriers of conception.
-
ISO 20417 has been updated – what device manufacturers should consider
The new edition of ISO 20417 has been published, further clarifying expectations for information supplied with medical devices. Although not yet harmonized, the...
-
A tiny animal with great importance
From the mythical Ganges River to the less sacred, but considerably cleaner waters in KI's aquariums in Solna. The little zebrafish has made an unconscious care...
-
A new scientific event in Gothenburg
Life Science Sweden is holding an event in Gothenburg for the first time.
-
FDA leaders seek to scrap two-study requirement
A single pivotal study may be sufficient to secure approval for a new medicine in the United States. That is the message delivered by FDA Commissioner Marty Mak...
-
“The US matters most – even in times of turbulence”
Tariffs, geopolitical uncertainty and rapidly changing trade conditions mean that Swedish life science companies need more routes into global markets – and fast...
-
Acne medication may be the solution when hair starts falling out
A treatment originally developed for acne has shown remarkable Phase III results in a completely different area: male-pattern hair loss.
-
Breakthrough devices: Key insights from MDCG 2025-9 guidance
The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical De...
-
Hajpad genterapi mot blödarsjuka dras in
Roctavian, den första och enda genterapin mot hemofili A, dras in från marknaden. Orsaken är att den blivit en kommersiell flopp.
-
Insurance in Life Science: From risk to resilience
Are you visiting The Future of Swedish & Danish Life Science event in Lund 23 April? Don't miss the Gallagher seminar on Risk and Insurance in the Life Sciences sector.
-
Top 10 biggest drug launches 2026
Two presumed sales rockets – both in obesity and type 2 diabetes – top a list of potential blockbusters expected to launch in the United States in 2026.
-
“Research is always a lot of failures and a few successes”
Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...
-
Gothenburg-based Anyo Labs gains ground in the AI race
In a fifty-square-metre space in Gothenburg sits a company aiming to secure its place on one of the world's hottest technological stages: AI-driven drug develop...
-
Novo Nordisk Foundation commits billions to Danish life science incubator
The Novo Nordisk Foundation grants up to DKK 5.5 billion to life science and deep‑tech incubator Bioinnovation Institute (BII) in Copenhagen.
-
Positive outcome in phase III for Sanofi’s eczema treatment
The antibody amlitelimab shows positive Phase III data as a treatment for atopic dermatitis. France‑based Sanofi now plans to submit global regulatory applicati...
-
The Beauty of Clinical Microscopy of Urine Sediment
Read about concrete observations using phase contrast and polarized light.
-
Transport validation for medical devices
According to MDR 2017/745, “Devices shall be designed and manufactured in such a way as to ensure that their characteristics and performance during their intend...
-
Enhancing Spatial Biology
Enabling easy, reproducible multiplex spatial profiling at scale.
-
“There’s no magic wand” – The urgent need for new treatments
One in ten women with recurrent yeast infections develops a stubborn, hard-to-treat condition for which no effective therapies currently exist. At Danderyd Hosp...
-
Fourteen US-based top researchers recruited to Sweden
Sweden has set its sights on America’s top scholars – and it seems to work. By the end of 2025, fourteen leading U.S.-based researchers had already been won ove...
-
ZEISS Quality Innovations Worldwide
All events now in one video.
-
Collaboration across the Øresund – Camurus enters Danish licensing agreement
Lund‑based Camurus has entered into a collaboration and licensing agreement with Danish company Gubra, which specializes in peptide‑based drug development.
BREAKING